Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · IEX Real-Time Price · USD
0.949
-0.001 (-0.09%)
At close: Apr 12, 2024, 4:00 PM
0.931
-0.018 (-1.91%)
After-hours: Apr 15, 2024, 6:23 PM EDT

Rapid Micro Biosystems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Revenue
22.5217.1323.2316.0816.51
Revenue Growth (YoY)
31.44%-26.25%44.50%-2.63%-
Cost of Revenue
2825.6730.9724.1516.75
Gross Profit
-5.49-8.54-7.74-8.07-0.23
Selling, General & Admin
38.2641.8129.7115.9412.97
Research & Development
12.8212.879.786.535.43
Operating Expenses
51.0854.6839.4922.4718.4
Operating Income
-56.56-63.22-47.23-30.54-18.63
Interest Expense / Income
-4.21-1.782.613.452.38
Other Expense / Income
0.08-0.0623.592.96-0.27
Pretax Income
-52.44-61.38-73.43-36.94-20.74
Income Tax
0.03-0.580.090.130.43
Net Income
-52.47-60.81-73.52-37.08-21.17
Preferred Dividends
004.518.145.45
Net Income Common
-52.47-60.81-78.03-45.22-26.62
Shares Outstanding (Basic)
43422002
Shares Outstanding (Diluted)
43422002
Shares Change
1.34%114.59%5417.16%-79.34%-
EPS (Basic)
-1.22-1.43-3.94-126.11-15.34
EPS (Diluted)
-1.22-1.43-3.94-126.11-15.34
Free Cash Flow
-46.93-65.29-58.16-31.69-22.84
Free Cash Flow Per Share
-1.09-1.54-2.94-88.36-13.16
Gross Margin
-24.36%-49.85%-33.32%-50.20%-1.42%
Operating Margin
-251.18%-368.99%-203.31%-189.96%-112.85%
Profit Margin
-232.99%-354.91%-335.88%-281.28%-161.22%
Free Cash Flow Margin
-208.38%-381.06%-250.35%-197.09%-138.34%
EBITDA
-52.34-59.18-69.3-31.99-16.91
EBITDA Margin
-232.42%-345.42%-298.28%-198.97%-102.40%
Depreciation & Amortization
4.313.981.531.511.46
EBIT
-56.65-63.16-70.83-33.5-18.37
EBIT Margin
-251.55%-368.65%-304.86%-208.35%-111.25%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).